(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C

Modify Date: 2024-01-13 12:55:00

(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C Structure
(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C structure
Common Name (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C
CAS Number 478506-34-2 Molecular Weight 181.14900
Density N/A Boiling Point N/A
Molecular Formula C6H12O6 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C


(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C is the 13C labeled (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one. (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one is an endogenous metabolite[1].

 Names

Name l-[4-13c]sorbose
Synonym More Synonyms

  Biological Activity

Description (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C is the 13C labeled (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one. (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one is an endogenous metabolite[1].
Related Catalog
In Vitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.

 Chemical & Physical Properties

Molecular Formula C6H12O6
Molecular Weight 181.14900
Exact Mass 181.06700
PSA 110.38000

 Synonyms

L-Sorbose-4-13C